You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-ABL1 (ABL1) Antibodies

Full name:
anti-C-Abl Oncogene 1, Non-Receptor tyrosine Kinase Antibodies (ABL1)
On www.antibodies-online.com are 591 C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) Antibodies from 24 different suppliers available. Additionally we are shipping ABL1 Kits (25) and ABL1 Proteins (22) and many more products for this protein. A total of 695 ABL1 products are currently listed.
Synonyms:
Abl, ABL1, ABLL, AI325092, bcr/abl, c-Abl, CABL, cb272, E430008G22Rik, JTK7, MTP, p150, v-abl
list all antibodies Gene Name GeneID UniProt
ABL1 25 P00519
ABL1 11350 P00520
ABL1 311860  

Show all species

Show all synonyms

All available anti-ABL1 Antibodies

Go to our pre-filtered search.

Top referenced anti-ABL1 Antibodies

  1. Human Polyclonal ABL1 Primary Antibody for DB, IHC (p) - ABIN389501 : Barnes, McIntosh, Whetton, Daley, Bentley, Baldwin: Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation. in Oncogene 2005 (PubMed)
    Show all 6 references for ABIN389501

  2. Human Polyclonal ABL1 Primary Antibody for EIA, IHC (p) - ABIN358068 : Saglio, Cilloni: Abl: the prototype of oncogenic fusion proteins. in Cellular and molecular life sciences : CMLS 2004 (PubMed)
    Show all 5 references for ABIN358068

  3. Human Polyclonal ABL1 Primary Antibody for EIA, IHC (p) - ABIN359966 : Lockhart, Marthan, Charan, Paré: Airway circulation in health and disease. in The European respiratory journal 1996 (PubMed)
    Show all 5 references for ABIN359966

  4. Human Polyclonal ABL1 Primary Antibody for DB, IF - ABIN389865 : Kim, Cho, Yoon, Park, Kim, Lee, Chun, Kim, Lee et al.: Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra ... in Genes, chromosomes & cancer 2005 (PubMed)
    Show all 5 references for ABIN389865

  5. Human Polyclonal ABL1 Primary Antibody for EIA, IHC (p) - ABIN359968 : Vasquez, Boeckx, Brosens: Prospective study of tubal mucosal lesions and fertility in hydrosalpinges. in Human reproduction (Oxford, England) 1995 (PubMed)
    Show all 5 references for ABIN359968

  6. Human Polyclonal ABL1 Primary Antibody for ELISA, WB - ABIN1532033 : Fainstein, Einat, Gokkel, Marcelle, Croce, Gale, Canaani: Nucleotide sequence analysis of human abl and bcr-abl cDNAs. in Oncogene 1990 (PubMed)
    Show all 3 references for ABIN1532033

  7. Human Polyclonal ABL1 Primary Antibody for IF, ELISA - ABIN1531424 : Chissoe, Bodenteich, Wang, Wang, Burian, Clifton, Crabtree, Freeman, Iyer, Jian: Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. in Genomics 1995 (PubMed)
    Show all 3 references for ABIN1531424

  8. Mouse (Murine) Polyclonal ABL1 Primary Antibody for IHC (p), WB - ABIN657828 : Ko, Lee, Shin, Karuppagounder, Gadad, Koleske, Pletnikova, Troncoso, Dawson, Dawson: Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. in Proceedings of the National Academy of Sciences of the United States of America 2010 (PubMed)
    Show all 2 references for ABIN657828

  9. Human Polyclonal ABL1 Primary Antibody for IF, IHC - ABIN1531765 : Krapivinsky, Medina, Krapivinsky, Gapon, Clapham: SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. in Neuron 2004 (PubMed)

  10. Human Polyclonal ABL1 Primary Antibody for WB - ABIN392079 : Donaldson, Gish, Pawson, Kay, Forman-Kay: Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. in Proceedings of the National Academy of Sciences of the United States of America 2002 (PubMed)

More Antibodies against ABL1 Interaction Partners

Human C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) interaction partners

  1. the N-terminal domain of MTP is important for its lipid transfer activity

  2. By visually examining the dynamics behavior, structural basis and energetic property of few typical Abl-drug complex cases, a significantly different pattern of non-bonded interactions between the binding of drug ligands to Abl receptor was revealed.

  3. Identify a novel BCR-ABL/IkappaBalpha (show NFKBIA Antibodies)/p53 (show TP53 Antibodies) network, whereby BCR-ABL functionally inactivates a key tumor suppressor in chronic myeloid leukemia (show BCL11A Antibodies).

  4. Blockade of the interaction between Bcr-Abl and PTB1B by small molecule SBF-1 (show SBF1 Antibodies) to overcomes imatinib-resistance of K562 cells.

  5. BCR-ABL1 transcript types found in Syria were similar to that of Indian Far-Eastern, African or European populations. The M-BCR rearrangement types were not dependent on white blood count, platelet count, hemoglobin level or gender of the patients.

  6. Data suggest elevated interleukin-1beta secretion from tyrosine kinase (show TXK Antibodies) inhibitor- (TKI-)resistant chronic myeloid leukemia (show BCL11A Antibodies) (CML (show BCR Antibodies)) cells contributes to TKI/imatinib resistance via promotion of cell viability/migration; cells used lack BCR-ABL mutation.

  7. Our results link FGF8 (show FGF8 Antibodies), c-Abl and p300 (show EP300 Antibodies) in a regulatory pathway that controls DeltaNp63alpha protein stability and transcriptional activity.

  8. Suggest that AIC-47 in combination with imatinib strengthened the attack on cancer energy metabolism in BCR-ABL-harboring leukemic cells.

  9. Molecular rearrangements and the minimal residual disease follow-up for 5 chronic myeloid leukaemia patients; 3 resulted from new rearrangements between the BCR (show BCR Antibodies) and ABL1 sequences (the breakpoints being located within BCR (show BCR Antibodies) exon 13 in 2 cases and within BCR (show BCR Antibodies) exon 18 in one case). The other 2 cases revealed a complex e8-[ins (show INS Antibodies)]-a2 fusion transcript involving a 3rd partner gene.

  10. analysis of WT1 and M-BCR-ABL expressions in chronic myeloid leukemia reveals that high WT1 expression in CML patients is detected especially in the advanced stages of the disease

Mouse (Murine) C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) interaction partners

  1. Our data show that: i) HDAC2 (show HDAC2 Antibodies) levels and activity are increased in NPC (show NPC1 Antibodies) neuronal models and in Npc1 (show NPC1 Antibodies)(-/-) mice; ii) inhibition of c-Abl or c-Abl deficiency prevents the increase of HDAC2 (show HDAC2 Antibodies) protein levels and activity in NPC (show NPC1 Antibodies) neuronal models

  2. The resistance in BCR (show BCR Antibodies)-ABL1 cells resulted either from the Y253H mutation in the BCR (show BCR Antibodies)-ABL1 gene or incubation in increasing concentrations of imatinib.

  3. These results reveal a new pathway in the DNA damage response wherein ABL-dependent tyrosine phosphorylation of DGCR8 (show DGCR8 Antibodies) stimulates the processing of selective primary miRNAs.

  4. These findings connect the EphB signaling pathway to the regulation of intestinal adenoma initiation via Abl kinase.

  5. overexpression of Id2 in primary alveolar epithelial cells promotes proliferation by inhibiting a retinoblastoma protein/c-Abl interaction leading to greater c-Abl activity.

  6. The study demonstrates a previously unrecognized mechanism that controls insulin (show INS Antibodies) expression through c-Abl-regulated NKx2.2 (show Nkx2-2 Antibodies) and GLUT2 (show SLC2A2 Antibodies).

  7. Oocyte-specific inactivation of Omcg1 leads to DNA damage and c-Abl/TAp63-dependent oocyte death associated with dramatic remodeling of ovarian somatic cells.

  8. LPS-induced paxillin phosphorylation at Y31 and Y118 was mediated by c-Abl tyrosine kinase

  9. c-Abl modulates tumor cell sensitivity to antibody-dependent cellular cytotoxicity.

  10. Data (including data from mouse mutant strains) suggest that neuropilin-1 (show NRP1 Antibodies) in vascular endothelium contributes to angiogenesis via VEGFA (show VEGFA Antibodies)-independent mechanism involving Abl1 signaling in the extracellular matrix in VEGFA (show VEGFA Antibodies)-independent mechanism. [REVIEW]

Caenorhabditis elegans (C. elegans) C-Abl Oncogene 1, Non-Receptor tyrosine Kinase (ABL1) interaction partners

  1. By screening candidate genes involved in Eph (show EPHA1 Antibodies) signaling, we find that the Eph (show EPHA1 Antibodies) kinase-independent pathway involves the ABL-1 nonreceptor tyrosine kinase (show TYRO3 Antibodies) and possibly the phosphatidylinositol 3-kinase pathway

  2. The trade-off in immunological susceptibility in C. elegans is further mediated by the reciprocal activity of lys (show LYZ Antibodies)-7 and the tyrosine kinase abl-1.

  3. oxidative, osmotic, heat shock and starvation stresses induce germ cell apoptosis through a p53 (show TP53 Antibodies) and EGL-1 independent pathway; the MAPK (show MAPK1 Antibodies) kinases MEK-1 (show MAP2K1 Antibodies) and SEK-1 (show MAP2K4 Antibodies), and the p53 (show TP53 Antibodies) antagonist protein ABL-1, are essential for stress-induced germ cell apoptosis

  4. findings demonstrate that ABL-1, the C. elegans homolog of the mammalian c-Abl nonreceptor tyrosine kinase (show TYRO3 Antibodies) ABL1, is required for Shigella flexneri pathogenesis in nematodes

ABL1 Antigen Profile

Antigen Summary

MTP encodes the large subunit of the heterodimeric microsomal triglyceride transfer protein. Protein disulfide isomerase (PDI) completes the heterodimeric microsomal triglyceride transfer protein, which has been shown to play a central role in lipoprotein assembly. Mutations in MTP can cause abetalipoproteinemia.

Alternative names and synonyms associated with ABL1

  • c-abl oncogene 1, receptor tyrosine kinase (ABL1) antibody
  • c-abl oncogene 1, non-receptor tyrosine kinase (ABL1) antibody
  • v-abl Abelson murine leukemia viral oncogene homolog 2 (ABL2) antibody
  • v-abl Abelson murine leukemia viral oncogene homolog 2 (abl2) antibody
  • c-abl oncogene 1, non-receptor tyrosine kinase (Abl1) antibody
  • microsomal triglyceride transfer protein (MTTP) antibody
  • Protein ABL-1 (abl-1) antibody
  • Abl antibody
  • ABL1 antibody
  • ABLL antibody
  • AI325092 antibody
  • bcr/abl antibody
  • c-Abl antibody
  • CABL antibody
  • cb272 antibody
  • E430008G22Rik antibody
  • JTK7 antibody
  • MTP antibody
  • p150 antibody
  • v-abl antibody

Protein level used designations for ABL1

c-abl oncogene 1, receptor tyrosine kinase , v-abl Abelson murine leukemia viral oncogene homolog 1 , Abelson murine leukemia viral (v-abl) oncogene homolog 1 , v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) , tyrosine kinase ABL , Abelson murine leukemia viral (v-abl) oncogene homolog 2 , Abelson tyrosine-protein kinase 2 , arg, Abelson-related , tyrosine-protein kinase ABL2 , v-abl Abelson murine leukemia viral oncogene homolog 2 , arg tyrosine kinase , tyrosine-protein kinase ABL2-like , Abelson tyrosine-protein kinase 1 , bcr/c-abl oncogene protein , proto-oncogene c-Abl , proto-oncogene tyrosine-protein kinase ABL1 , tyrosine-protein kinase ABL1 , Abelson murine leukemia oncogene , abelson murine leukemia viral oncogene homolog 1 , p150 , v-abl Abelson murine leukemia oncogene 1 , v-abl Abelson murine leukemia viral oncogene 1 , microsomal triglyceride transfer protein (large polypeptide, 88kDa) , microsomal triglyceride transfer protein large subunit

GENE ID SPECIES
280970 Bos taurus
417181 Gallus gallus
464802 Pan troglodytes
491292 Canis lupus familiaris
395410 Gallus gallus
457552 Pan troglodytes
511845 Bos taurus
570636 Danio rerio
717037 Macaca mulatta
100348328 Oryctolagus cuniculus
100463896 Ailuropoda melanoleuca
100543723 Meleagris gallopavo
100588798 Nomascus leucogenys
25 Homo sapiens
540876 Bos taurus
11350 Mus musculus
311860 Rattus norvegicus
4547 Homo sapiens
181261 Caenorhabditis elegans
Selected quality suppliers for anti-ABL1 (ABL1) Antibodies
Did you look for something else?